ValueinValuein

YDESYD Bio Ltd

Health Care

Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs revised down 5.7% for FY 2024

This is the 4th largest revision in YDES's history.

Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs

FY 2024

Notable restatement

As reported

$8.5M

Restated

$8M
-5.7%
Verify against SEC filingsShow
As reported$8.5M
Accepted 2026-04-300001213900-26-050282
Restated$8M
Accepted 2026-05-260001213900-26-061106

AdditionalPaidInCapital · reported 3 times · point-in-time, survivorship-free. Every figure traces to its filing above.

Track this the moment it happens

Get an alert the next time YDES — or any company on your watchlist — restates a number. Every alert lands with the diff and its source filing.